The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Hematological findings and complications of COVID‐19
Open accessAbstract
COVID‐19 is a systemic infection with a significant impact on the hematopoietic system and hemostasis. Lymphopenia may be considered as a cardinal laboratory finding, with prognostic potential. Neutrophil/lymphocyte ratio and peak platelet/lymphocyte ratio may also have prognostic value in determining severe cases. During the disease course, longitudinal evaluation of lymphocyte count dynamics and inflammatory indices, including LDH, CRP and IL‐6 may help to identify cases with dismal prognosis and prompt intervention in order to improve outcomes. Biomarkers, such high serum procalcitonin and ferritin have also emerged as poor prognostic factors. Furthermore, blood hypercoagulability is common among hospitalized COVID‐19 patients. Elevated D‐Dimer levels are consistently reported, whereas their gradual increase during disease course is particularly associated with disease worsening. Other coagulation abnormalities such as PT and aPTT prolongation, fibrin degradation products increase, with severe thrombocytopenia lead to life‐threatening disseminated intravascular coagulation (DIC), which necessitates continuous vigilance and prompt intervention. So, COVID‐19 infected patients, whether hospitalized or ambulatory, are at high risk for venous thromboembolism, and an early and prolonged pharmacological thromboprophylaxis with low molecular weight heparin is highly recommended. Last but not least, the need for assuring blood donations during the pandemic is also highlighted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244 · cited 1×
“Note, SARS-CoV-2 is approximately 80% similar to SARS-CoV, and invades host human cells by binding to the angiotensin-converting enzyme 2 (ACE2) receptor.(1)Although it is well documented that COVID-19 is primarily manifested as a respiratory tract infection, emerging data indicate that it should be regarded as a syst…”
BackgroundZhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066
COVID-19: consider cytokine storm syndromes and immunosuppression
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664
Cited by
Extrapulmonary manifestations of COVID-19
Gupta, A., Madhavan, M. V., Sehgal, K., Nair, N., Mahajan, S., Sehrawat, T. S., Bikdeli, B., Ahluwalia, N., Ausiello, J. C., Wan, E. Y., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0968-3 · Cited by 3,185
Immunology of COVID-19: Current State of the Science
Vabret, N., Britton, G. J., Gruber, C., Hegde, S., Kim, J., Kuksin, M., Levantovsky, R., Malle, L., Moreira, A., Park, M. D., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.05.002 · Cited by 1,623
Middleton, E. A., He, X.-Y., Denorme, F., Campbell, R. A., Ng, D., Salvatore, S. P., Mostyka, M., Baxter-Stoltzfus, A., Borczuk, A. C., Loda, M., et al. (2020) · Blood · doi:10.1182/blood.2020007008 · Cited by 1,460
Why does COVID-19 disproportionately affect older people?
Mueller, A. L., McNamara, M. S., & Sinclair, D. A. (2020) · Aging · doi:10.18632/aging.103344 · Cited by 1,128
Biomarkers associated with COVID-19 disease progression
Ponti, G., Maccaferri, M., Ruini, C., Tomasi, A., & Ozben, T. (2020) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2020.1770685 · Cited by 890
Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment
Soy, M., Keser, G., Atagündüz, P., Tabak, F., Atagündüz, I., & Kayhan, S. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-05190-5 · Cited by 811
The Stanford Hall consensus statement for post-COVID-19 rehabilitation
Barker-Davies, R. M., O"Sullivan, O., Senaratne, K. P. P., Baker, P., Cranley, M., Dharm-Datta, S., Ellis, H., Goodall, D., Gough, M., Lewis, S., et al. (2020) · British Journal of Sports Medicine · doi:10.1136/bjsports-2020-102596 · Cited by 750
Terpos, E., Engelhardt, M., Cook, G., Gay, F., Mateos, M.-V., Ntanasis-Stathopoulos, I., van de Donk, N. W. C. J., Avet-Loiseau, H., Hajek, R., Vangsted, A. J., et al. (2020) · Leukemia · doi:10.1038/s41375-020-0876-z · Cited by 736
Self-citationThe hypercoagulable state in COVID-19: Incidence, pathophysiology, and management
Abou-Ismail, M. Y., Diamond, A., Kapoor, S., Arafah, Y., & Nayak, L. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.06.029 · Cited by 694
Risk and Protective Factors for COVID-19 Morbidity, Severity, and Mortality
Zhang, J.-J., Dong, X., Liu, G.-H., & Gao, Y.-D. (2022) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-022-08921-5 · Cited by 715
Pretorius, E., Vlok, M., Venter, C., Bezuidenhout, J. A., Laubscher, G. J., Steenkamp, J., & Kell, D. B. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01359-7 · Cited by 518
Organ-specific manifestations of COVID-19 infection
Gavriatopoulou, M., Korompoki, E., Fotiou, D., Ntanasis-Stathopoulos, I., Psaltopoulou, T., Kastritis, E., Terpos, E., & Dimopoulos, M. A. (2020) · Clinical and Experimental Medicine · doi:10.1007/s10238-020-00648-x · Cited by 502
Self-citationCOVID-19 and multiorgan failure: A narrative review on potential mechanisms
Mokhtari, T., Hassani, F., Ghaffari, N., Ebrahimi, B., Yarahmadi, A., & Hassanzadeh, G. (2020) · Journal of Molecular Histology · doi:10.1007/s10735-020-09915-3 · Cited by 439
COVID-19: from an acute to chronic disease? Potential long-term health consequences
Higgins, V., Sohaei, D., Diamandis, E. P., & Prassas, I. (2021) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2020.1860895 · Cited by 405
Pathology and Pathogenesis of SARS-CoV-2 Associated with Fatal Coronavirus Disease, United States
Martines, R. B., Ritter, J. M., Matkovic, E., Gary, J., Bollweg, B. C., Bullock, H., Goldsmith, C. S., Silva-Flannery, L., Seixas, J. N., Reagan-Steiner, S., et al. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2609.202095 · Cited by 381
The complement system in COVID-19: friend and foe?
Java, A., Apicelli, A. J., Liszewski, M. K., Coler-Reilly, A., Atkinson, J. P., Kim, A. H. J., & Kulkarni, H. S. (2020) · JCI Insight · doi:10.1172/jci.insight.140711 · Cited by 376
Covid‐19 and kidney injury: Pathophysiology and molecular mechanisms
Ahmadian, E., Hosseiniyan Khatibi, S. M., Razi Soofiyani, S., Abediazar, S., Shoja, M. M., Ardalan, M., & Zununi Vahed, S. (2021) · Reviews in Medical Virology · doi:10.1002/rmv.2176 · Cited by 366
Doglietto, F., Vezzoli, M., Gheza, F., Lussardi, G. L., Domenicucci, M., Vecchiarelli, L., Zanin, L., Saraceno, G., Signorini, L., Panciani, P. P., et al. (2020) · JAMA Surgery · doi:10.1001/jamasurg.2020.2713 · Cited by 356
Radermecker, C., Detrembleur, N., Guiot, J., Cavalier, E., Henket, M., d’Emal, C., Vanwinge, C., Cataldo, D., Oury, C., Delvenne, P., et al. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20201012 · Cited by 349
The Systemic Inflammation Index on Admission Predicts In-Hospital Mortality in COVID-19 Patients
Fois, A. G., Paliogiannis, P., Scano, V., Cau, S., Babudieri, S., Perra, R., Ruzzittu, G., Zinellu, E., Pirina, P., Carru, C., et al. (2020) · Molecules · doi:10.3390/molecules25235725 · Cited by 349
Emerging treatment strategies for COVID-19 infection
Gavriatopoulou, M., Ntanasis-Stathopoulos, I., Korompoki, E., Fotiou, D., Migkou, M., Tzanninis, I.-G., Psaltopoulou, T., Kastritis, E., Terpos, E., & Dimopoulos, M. A. (2021) · Clinical and Experimental Medicine · doi:10.1007/s10238-020-00671-y · Cited by 326
Self-citationCOVID-19 Transmission, Current Treatment, and Future Therapeutic Strategies
Salian, V. S., Wright, J. A., Vedell, P. T., Nair, S., Li, C., Kandimalla, M., Tang, X., Carmona Porquera, E. M., Kalari, K. R., & Kandimalla, K. K. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00608 · Cited by 315
Systemic and organ-specific immune-related manifestations of COVID-19
Ramos-Casals, M., Brito-Zerón, P., & Mariette, X. (2021) · Nature Reviews Rheumatology · doi:10.1038/s41584-021-00608-z · Cited by 309
Mitochondria and microbiota dysfunction in COVID-19 pathogenesis
Saleh, J., Peyssonnaux, C., Singh, K. K., & Edeas, M. (2020) · Mitochondrion · doi:10.1016/j.mito.2020.06.008 · Cited by 305
Biomarkers in COVID-19: An Up-To-Date Review
Samprathi, M., & Jayashree, M. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2020.607647 · Cited by 290
Body Localization of ACE-2: On the Trail of the Keyhole of SARS-CoV-2
Salamanna, F., Maglio, M., Landini, M. P., & Fini, M. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.594495 · Cited by 281
Bae, S., Kim, S. R., Kim, M.-N., Shim, W. J., & Park, S.-M. (2021) · Heart · doi:10.1136/heartjnl-2020-317901 · Cited by 280
Trougakos, I. P., Stamatelopoulos, K., Terpos, E., Tsitsilonis, O. E., Aivalioti, E., Paraskevis, D., Kastritis, E., Pavlakis, G. N., & Dimopoulos, M. A. (2021) · Journal of Biomedical Science · doi:10.1186/s12929-020-00703-5 · Cited by 278
Self-citationSARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes
Ferreira, A. C., Soares, V. C., de Azevedo-Quintanilha, I. G., Dias, S. D. S. G., Fintelman-Rodrigues, N., Sacramento, C. Q., Mattos, M., de Freitas, C. S., Temerozo, J. R., Teixeira, L., et al. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00428-w · Cited by 273
The value of clinical parameters in predicting the severity of COVID‐19
Shang, W., Dong, J., Ren, Y., Tian, M., Li, W., Hu, J., & Li, Y. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26031 · Cited by 270
Retinal findings in patients with COVID-19: Results from the SERPICO-19 study
Invernizzi, A., Torre, A., Parrulli, S., Zicarelli, F., Schiuma, M., Colombo, V., Giacomelli, A., Cigada, M., Milazzo, L., Ridolfo, A., et al. (2020) · eClinicalMedicine · doi:10.1016/j.eclinm.2020.100550 · Cited by 266
Madhavan, M. V., Bikdeli, B., Gupta, A., Jimenez, D., Burton, J. R., Der Nigoghossian, C., Chuich, T., Nouri, S. N., Dreyfus, I., Driggin, E., et al. (2020) · Thrombosis and Haemostasis · doi:10.1055/s-0040-1713152 · Cited by 258
The Role of Ferritin in Health and Disease: Recent Advances and Understandings
Kotla, N. K., Dutta, P., Parimi, S., & Das, N. K. (2022) · Metabolites · doi:10.3390/metabo12070609 · Cited by 132
The looming storm: Blood and cytokines in COVID-19
Kaur, S., Bansal, R., Kollimuttathuillam, S., Gowda, A. M., Singh, B., Mehta, D., & Maroules, M. (2021) · Blood Reviews · doi:10.1016/j.blre.2020.100743 · Cited by 113
Carubbi, F., Salvati, L., Alunno, A., Maggi, F., Borghi, E., Mariani, R., Mai, F., Paoloni, M., Ferri, C., Desideri, G., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-83831-8 · Cited by 104
Cheung, S., Quiwa, J. C., Pillai, A., Onwu, C., Tharayil, Z. J., & Gupta, R. (2020) · American Journal of Case Reports · doi:10.12659/ajcr.925753 · Cited by 90
Excess mortality in the United States during the first three months of the COVID-19 pandemic
Rivera, R., Rosenbaum, J. E., & Quispe, W. (2020) · Epidemiology and Infection · doi:10.1017/s0950268820002617 · Cited by 83
Marked factor V activity elevation in severe COVID‐19 is associated with venous thromboembolism
Stefely, J. A., Christensen, B. B., Gogakos, T., Cone Sullivan, J. K., Montgomery, G. G., Barranco, J. P., & Van Cott, E. M. (2020) · American Journal of Hematology · doi:10.1002/ajh.25979 · Cited by 80
Modulation of endothelial organelle size as an antithrombotic strategy
Ferraro, F., Patella, F., Costa, J. R., Ketteler, R., Kriston‐Vizi, J., & Cutler, D. F. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15084 · Cited by 19
COVID-19 and intestinal ischemia: a multicenter case series
Sarkardeh, M., Meftah, E., Mohammadzadeh, N., Koushki, J., & Sadrzadeh, Z. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.879996 · Cited by 13
“D-dimer is a predictive factor of disease severity and mortality among COVID-19 patients (8, 13, 27, 28) and is also suggestive of thrombotic microangiopathy (13, 14).”
BackgroundResultCOVID-19 induced mesenteric venous infarction
Calcagno, E., Sogunro, O., Nepal, P., Assaker, R., & Sapire, J. (2021) · Radiology Case Reports · doi:10.1016/j.radcr.2021.04.083 · Cited by 8
SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE: COVID-19 and Hematology
Kreidieh, F., & Temraz, S. (2020) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2020.078 · Cited by 7
Deep learning with robustness to missing data: A novel approach to the detection of COVID-19
Çallı, E., Murphy, K., Kurstjens, S., Samson, T., Herpers, R., Smits, H., Rutten, M., & van Ginneken, B. (2021) · PLOS ONE · doi:10.1371/journal.pone.0255301 · Cited by 6
Metadata
- Authors
- Terpos, E., Ntanasis‐Stathopoulos, I., Elalamy, I., Kastritis, E., Sergentanis, T. N., Politou, M., Psaltopoulou, T., Gerotziafas, G., & Dimopoulos, M. A.
- Venue
- American Journal of Hematology
- Publisher
- Wiley
- Published
- 2020-05-23
- Volume
- 95
- Issue
- 7
- Pages
- 834-847
- ISSN
- 0361-8609 (ISSN-L)
- 1096-8652
- OpenAlex
- W3016126001
- Cited by
- 1,673
- References
- 47
- FWCI
- 44.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.